J&J Team Up With China’s Tinavi; A Much Needed Boost For Spine Business?
Executive Summary
A new co-marketing agreement with Chinese orthopedics group Tinavi could be key in turning round Johnson & Johnson’s spine business, according to executives. The collaboration will allow J&J’s DePuy Synthes business, to sell the TiRobot for spine and trauma surgery in the Chinese market.
You may also be interested in...
J&J’s Investment In Medical Device Businesses Is Starting To Pay Off
Johnson & Johnson's medical device businesses grew 5.3% on an organic basis in the third quarter, led by the Biosense Webster electrophysiology business. The company is increasing R&D investment, especially in robotic surgery, to boost its surgery and orthopedics businesses.
Johnson & Johnson Diversifies Robotic Efforts With Auris Health Aquisition
Johnson & Johnson will acquire robotic startup Auris Health for $3.4bn in cash, plus milestones payments of up to $2.4bn. Auris developed the FDA-cleared Monarch platform, which is expected to rival Intuitive Surgical's robotic-assisted bronchoscope device, Ion, awaiting FDA clearance.
Qiagen’s Ambitions: Standing Alone And Strengthening Infectious Disease Portfolio
Qiagen official Antoine Marchal outlines how NeuModx will strengthen its position in the infectious disease space.